WO2025173029 - AN IMPROVED PROCESS FOR THE PREPARATION OF DEUCRAVACITINIB
National phase entry is expected:
Publication Number
WO/2025/173029
Publication Date
21.08.2025
International Application No.
PCT/IN2025/050191
International Filing Date
12.02.2025
Title **
[English]
AN IMPROVED PROCESS FOR THE PREPARATION OF DEUCRAVACITINIB
[French]
PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION DE DEUCRAVACITINIB
Applicants **
NATCO PHARMA LIMITED
Inventors
PULA, Subba Rao
GORJA, Sankara Rao
KARNAM, Sandeep
PULUGU, Venkata Eeswara Reddy
DANDALA, Ramesh
MUDDASANI, Pulla Reddy
NANNAPANENI, Venkaiah Chowdary
Priority Data
202441010287
14.02.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1958 | |
| EPO | Filing, Examination, Granting | 11708 | |
| Japan | Filing, Examination, Granting | 1979 | |
| South Korea | Filing, Examination, Granting | 1628 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
22,613
Abstract[English]
The present invention provides an improved process for the preparation of 5 Deucravacitinib of Formula-(I),[French]
La présente invention concerne un procédé amélioré pour la préparation de deucravacitinib de formule (I),